MME and endothelial dysfunction: In addition, LCZ696 suppressed the angiotensin II receptor and neprilysin simultaneously and improved endothelial dysfunction, cardiac dysfunction, sympathetic activation, sodium retention and ischemia–reperfusion injury in animal and clinical studies, suggesting a possible anti-atherogenic role of LCZ6964,9.